Constellation Pharmaceuticals, Inc. (CNST) Financial Statements (2024 and earlier)

Company Profile

Business Address 215 FIRST STREET
CAMBRIDGE, MA 02142
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2021
MRQ
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 421,448383,934114,592
Cash and cash equivalents 163,693334,332114,592
Short-term investments 257,75549,602 
Other undisclosed current assets 7,1613,0552,711
Total current assets: 428,609386,989117,303
Noncurrent Assets
Operating lease, right-of-use asset 3,54110,745
Property, plant and equipment 1,4979711,210
Restricted cash and investments 3,233425425
Other undisclosed noncurrent assets 4,974  
Total noncurrent assets: 13,24512,1411,635
TOTAL ASSETS: 441,854399,130118,938
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 15,86511,9898,704
Employee-related liabilities 5,5454,5272,726
Accounts payable 9,8537,2785,723
Accrued liabilities 467184255
Debt  2,562 
Other liabilities 341497346
Other undisclosed current liabilities 14,3427,7075,610
Total current liabilities: 30,54822,75514,660
Noncurrent Liabilities
Long-term debt and lease obligation 58238,401 
Long-term debt, excluding current maturities  29,642 
Liabilities, other than long-term debt  390120
Deferred rent credit   118
Other liabilities  3902
Operating lease, liability 5828,759
Other undisclosed noncurrent liabilities (582)  
Total noncurrent liabilities: 58238,791120
Total liabilities: 31,13061,54614,780
Equity
Equity, attributable to parent 410,724337,584104,158
Common stock 543
Additional paid in capital 856,460656,973337,992
Accumulated other comprehensive income (loss) 3(6) 
Accumulated deficit (445,744)(319,387)(233,837)
Total equity: 410,724337,584104,158
TOTAL LIABILITIES AND EQUITY: 441,854399,130118,938

Income Statement (P&L) ($ in thousands)

3/31/2021
TTM
12/31/2020
12/31/2019
12/31/2018
Revenues
(Sublease Income)
 220199 
Gross profit: 220199 
Operating expenses (124,847)(86,055)(61,244)
Other undisclosed operating loss (220)(199) 
Operating loss: (124,847)(86,055)(61,244)
Nonoperating income (expense) (1,471)5291,319
Investment income, nonoperating 2,8512,6441,547
Interest and debt expense (1,501)(2,115)(228)
Loss from continuing operations before equity method investments, income taxes: (127,819)(87,641)(60,153)
Other undisclosed income from continuing operations before income taxes 1,5012,115 
Loss from continuing operations before income taxes: (126,318)(85,526)(60,153)
Income tax expense (39)(24) 
Loss from continuing operations: (126,357)(85,550)(60,153)
Loss before gain (loss) on sale of properties:(126,357)(85,550)(60,153)
Other undisclosed net income   228
Net loss attributable to parent: (126,357)(85,550)(59,925)
Other undisclosed net loss available to common stockholders, basic  (6) 
Net loss available to common stockholders, diluted: (126,357)(85,556)(59,925)

Comprehensive Income ($ in thousands)

3/31/2021
TTM
12/31/2020
12/31/2019
12/31/2018
Net loss: (126,357)(85,550)(59,925)
Comprehensive loss: (126,357)(85,550)(59,925)
Other undisclosed comprehensive income, net of tax, attributable to parent 9  
Comprehensive loss, net of tax, attributable to parent: (126,348)(85,550)(59,925)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: